By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sanwa Kagaku Kenkyusho., Ltd. (SKK) 

35 Higashisotobori-cho

Higashi-ku  Nagoya  461-8631  Japan
Phone: 81-52-951-8130 Fax: 81-52-957-1066



Company News
Catalent Pharma Solutions and Sanwa Kagaku Kenkyusho., Ltd. (SKK) Announce Exclusive License For OSDrC(R) Technology, Bringing New Modified Release Delivery Technology to the Rx and OTC Global Market 7/14/2011 10:14:07 AM
Shanghai ChemPartner Co., Ltd. and Sanwa Kagaku Kenkyusho., Ltd. (SKK) Announce Strategic Alliance 4/20/2009 10:45:36 AM
VistaGen Therapeutics, Inc. Licenses Customized Stem Cell-Based Drug Discovery Assays to Sanwa Kagaku Kenkyusho, a Japanese Pharmaceutical Company 5/22/2008 10:08:17 AM
VistaGen Therapeutics, Inc. And Sanwa Kagaku Kenkyusho Renew Embryonic Stem Cell Drug Discovery And Development Partnership Focused On New Diabetes Treatments 11/30/2006 11:05:59 AM
4SC AG Enters Next Phase Of Drug Discovery Collaboration With Sanwa Kagaku Kenkyusho 1/17/2006 10:29:18 AM
Sanwa Kagaku Kenkyusho Releases SEIBULE, Miglitol Agent For Controlling Postprandical Blood Glucose 1/11/2006 1:26:05 PM
Allergan Inc. (AGN) And Sanwa Kagaku Kenkyusho Sign Exclusive Licensing Agreement To Develop And Market POSURDEX(R) In Japan10/19/2005 5:13:07 PM
4SC AG And Sanwa Kagaku Kenkyusho Enter Into Multi-Year Drug Discovery Collaboration10/19/2005 5:12:44 PM
Sanwa Kagaku Kenkyusho And Quark Biotech, Inc. Enter Collaboration To License Dyslipidemia Therapy10/19/2005 5:12:39 PM
VistaGen Therapeutics, Inc. And Sanwa Kagaku Kenkyusho Announce First Embryonic Stem Cell Research Partnership Focused On New Treatments For Diabetes 10/19/2005 5:11:49 PM